Neurology Minute podcast

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

0:00
2:57
Reculer de 15 secondes
Avancer de 15 secondes

Dr. Alberto Espay talks with Prof. Julian Gillmore about CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. Show references: https://www.nejm.org/doi/full/10.1056/NEJMoa2107454

D'autres épisodes de "Neurology Minute"